Ken Griffin Cytosorbents Corp Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cytosorbents Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 8,100 shares of CTSO stock, worth $7,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,100

Previous 16,000 49.38%

Holding current value

$7,047

Previous $14,000 42.86%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.89 - $1.3 $7,282 - $10,637	8,183 New	8,183 $8,000
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.55 $20,360 - $45,084	29,087 New	29,087 $43,000
Q3 2023 Nov 14, 2023	SELL	$1.86 - $4.03 $13,230 - $28,665	-7,113 Reduced 18.82%	30,688 $57,000
Q2 2023 Aug 14, 2023	BUY	$2.37 - $3.65 $58,323 - $89,822	24,609 Added 186.54%	37,801 $135,000
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $23,613 - $55,010	13,192 New	13,192 $44,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $183,560 - $335,833	104,296 Added 461.45%	126,898 $278,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $5,126 - $7,529	1,780 Added 8.55%	22,602 $73,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $164,976 - $330,360	-40,735 Reduced 66.17%	20,822 $87,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $210,994 - $292,678	30,142 Added 95.95%	61,557 $500,000
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $58,716 - $73,259	7,777 Added 32.9%	31,415 $237,000
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $375,024 - $523,120	-45,568 Reduced 65.84%	23,638 $205,000
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $463,567 - $544,161	-60,597 Reduced 46.68%	69,206 $552,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $251,788 - $394,252	34,164 Added 35.72%	129,803 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $535,005 - $902,183	85,192 Added 815.47%	95,639 $947,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $64,859 - $132,986	-17,204 Reduced 62.22%	10,447 $81,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $99,820 - $144,338	27,651 New	27,651 $106,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $94,939 - $124,767	-16,037 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.82 - $8.56 $32,367 - $40,625	4,746 Added 42.03%	16,037 $0
Q1 2018 May 11, 2018	BUY	$6.55 - $8.2 $73,956 - $92,586	11,291 New	11,291 $80,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account